Cost-Effectiveness Analysis of Three Drugs for Patients with Hypertension
- VernacularTitle:3种药物治疗原发性高血压的成本-效果分析
- Author:
Lina DENG
;
Yugang ZHANG
- Publication Type:Journal Article
- Keywords:
Hypertension;
Pharmacoeconomics;
Cost-effectiveness analysis
- From:
China Pharmacy
2007;0(32):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To compare the curative effects and pharmacoeconomical efficacy of three drugs in the treatment of patients with hypertension.METHODS:A total of 90 patients with hypertension were randomly divided into three groups:30(Group A) were treated with enalapril,30(Group B) with groLosartan,and 30(Group C) with metoprolol,all with a treatment course of 6wk.The clinical effects were observed and the cost-effectiveness analysis was conducted among the three schemes. RESULTS:The total effective rates of the 3 groups (A,B,and C) were 93.1%,96.7%,and 83.3%,respectively;the incidence rates of ADR were 10.3%,10.0%,and 16.7%,respectively;the cost-effectiveness ratios were 77.39,338.78,and 180.40,respectively;The incremental cost-effectiveness ratio of Group B and C were 7 098.61 and —798.16,respectively as against Group A.CONCLUSION:Group A(enalapril) treatment programs is a more reasonable drug program.